Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Oct 11 02:24PM ET
28.77
Dollar change
+1.56
Percentage change
5.71
%
IndexRUT P/E- EPS (ttm)-15.45 Insider Own10.86% Shs Outstand50.92M Perf Week-1.29%
Market Cap1.47B Forward P/E- EPS next Y-3.56 Insider Trans-0.33% Shs Float45.39M Perf Month1.18%
Income-185.98M PEG- EPS next Q-0.83 Inst Own92.41% Short Float19.04% Perf Quarter-0.09%
Sales0.00M P/S- EPS this Y92.59% Inst Trans108.69% Short Ratio17.74 Perf Half Y-23.25%
Book/sh4.30 P/B6.69 EPS next Y2.13% ROA-54.73% Short Interest8.64M Perf Year129.83%
Cash/sh8.37 P/C3.44 EPS next 5Y- ROE-222.71% 52W Range8.43 - 47.97 Perf YTD33.71%
Dividend Est.- P/FCF- EPS past 5Y1.60% ROI-49.68% 52W High-40.01% Beta2.93
Dividend TTM- Quick Ratio19.70 Sales past 5Y-49.91% Gross Margin39.53% 52W Low241.34% ATR (14)1.69
Dividend Ex-Date- Current Ratio19.70 EPS Y/Y TTM79.05% Oper. Margin0.00% RSI (14)52.55 Volatility4.70% 5.92%
Employees30 Debt/Eq0.00 Sales Y/Y TTM-100.00% Profit Margin- Recom1.11 Target Price47.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q98.49% Payout- Rel Volume0.19 Prev Close27.22
Sales Surprise-100.00% EPS Surprise9.45% Sales Q/Q-100.00% EarningsAug 07 AMC Avg Volume487.33K Price28.77
SMA200.75% SMA504.51% SMA200-3.90% Trades Volume72,126 Change5.71%
Date Action Analyst Rating Change Price Target Change
Sep-04-24Initiated Wedbush Outperform $45
Jul-16-24Initiated Evercore ISI Outperform
May-02-24Initiated Robert W. Baird Outperform $50
Mar-01-24Upgrade Wells Fargo Equal Weight → Overweight $12 → $35
Dec-20-23Initiated BTIG Research Buy $32
Dec-11-23Initiated Jefferies Buy $31
Dec-11-23Initiated Guggenheim Buy $44
May-04-20Initiated Piper Sandler Overweight $12
Mar-21-19Initiated JP Morgan Overweight $14
Sep-04-18Downgrade Wells Fargo Outperform → Market Perform
Oct-04-24 05:00PM
Oct-01-24 08:00AM
Sep-10-24 04:47PM
Aug-07-24 11:53PM
04:05PM
08:00AM Loading…
Jul-18-24 08:00AM
Jun-18-24 07:30AM
Jun-03-24 05:23PM
May-29-24 08:30AM
May-15-24 07:30AM
May-09-24 10:54PM
04:02PM
May-03-24 05:00PM
Apr-01-24 05:00PM
Mar-18-24 08:00AM
08:50AM Loading…
Mar-04-24 08:50AM
Mar-01-24 05:25PM
Feb-29-24 04:05PM
Feb-26-24 07:30AM
Feb-08-24 07:30AM
Feb-06-24 09:55AM
Feb-05-24 07:30AM
Feb-02-24 05:30PM
Dec-22-23 05:00PM
Dec-08-23 07:19AM
Dec-07-23 06:20PM
Nov-28-23 08:00AM
Nov-27-23 08:30AM
Nov-22-23 05:00PM
Nov-09-23 06:26PM
04:05PM Loading…
04:05PM
Nov-03-23 05:00PM
Oct-30-23 08:00PM
Oct-02-23 06:02PM
Sep-14-23 05:03PM
Sep-07-23 08:40AM
Sep-05-23 07:00AM
Aug-11-23 07:07AM
07:00AM
Jul-27-23 07:00AM
Jun-23-23 04:30PM
10:31AM
Jun-22-23 10:59AM
08:17AM
May-13-23 08:03AM
May-11-23 08:15AM
07:10AM
07:01AM
Apr-13-23 09:44AM
Apr-12-23 07:00AM
Mar-17-23 05:30PM
Mar-02-23 10:15AM
07:01AM
Feb-12-23 07:40AM
Jan-06-23 07:01AM
Jan-02-23 07:29AM
Dec-14-22 12:00PM
Dec-02-22 04:05PM
Nov-30-22 10:38AM
07:01AM
Nov-15-22 04:25PM
Nov-03-22 08:35AM
07:01AM
Oct-21-22 12:27PM
12:06PM
Oct-19-22 04:05PM
Oct-17-22 11:57AM
Oct-04-22 11:05AM
07:01AM
Aug-29-22 04:05PM
Aug-27-22 09:18AM
Aug-25-22 11:52AM
Aug-24-22 12:40PM
08:01AM
Aug-22-22 12:28PM
Aug-20-22 10:49AM
Aug-19-22 06:26AM
Aug-18-22 04:05PM
Aug-04-22 08:35AM
07:01AM
Jul-24-22 10:41AM
Jul-08-22 11:14AM
Jul-07-22 11:22AM
Jul-04-22 11:49AM
Jun-29-22 12:34PM
Jun-28-22 11:52AM
10:23AM
Jun-13-22 12:01PM
Jun-09-22 09:56AM
Jun-03-22 10:49AM
Jun-02-22 03:26PM
03:20PM
12:09PM
11:24AM
08:59AM
Jun-01-22 02:25PM
02:22PM
May-31-22 11:26AM
May-26-22 11:18AM
May-25-22 12:07PM
Spyre Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product, Pegzilarginase, is in a Phase 3 pivotal trial for the treatment of Arginase 1 Deficiency. The company was founded by George Georgiou and David G. Lowe on December 16, 2013 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burrows Scott LChief Financial OfficerSep 03 '24Sale28.1718,531522,074116,422Sep 05 04:04 PM
Fairmount Funds Management LLCDirectorApr 25 '24Option Exercise0.003,639,68004,018,101Apr 25 04:55 PM